Cancer Synergies
The effect of synergy exceeds...
| Rank | Combination | Cancer Targets | Evidence Level | Why It Exceeded Expectations |
| **1** | **Metformin + Aspirin** | Colorectal, breast, prostate | **Human RCT + epidemiology** | ↓ mTOR + ↓ platelet-mediated metastasis → far greater survival benefit than either alone |
| **2** | **Metformin + Doxycycline** | Breast, ovarian, lymphoma | **Human trials (CSC markers)** | Hits *bulk tumor metabolism* + *cancer stem cells* simultaneously |
| **3** | **Statin + Aspirin** | Prostate, colorectal | **Human observational + mechanistic** | Mevalonate blockade + anti-metastatic platelet inhibition |
| **4** | **Sulforaphane + Curcumin (bioavailable)** | Breast, colon, prostate | **Human biomarkers + animal** | Dual epigenetic + NF-κB suppression; strong CSC suppression |
| **5** | **EGCG + Quercetin** | Leukemia, prostate | **Human + animal** | Proteasome inhibition + senolytic pressure |
IMMORTALITY